MedTrace Logo

Impact of Discontinuing Contact Precautions for Extended-spectrum β-lactamase Enterobacteriaceae in a Geriatric Unit

NCT05475574 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 954

Last updated 2025-04-27

No results posted yet for this study

Summary

This is an interventional multicenter prospective noninferiority non-randomized double-blind controlled before and after study.

The aim of this study is to demonstrate that standard precautions alone are not inferior to contact precautions by comparing the incidence density of extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae acquired in geriatric units before and after discontinuing contact precautions.

Conditions

  • Infection, Hospital

Interventions

OTHER

Discontinuation of contact precautions for ESBLE

Discontinuation of contact precaution : only standard precaution are implemented for any patient carrying (infected or colonized) ESBLE

Sponsors & Collaborators

  • Centre Hospitalier Régional Metz-Thionville

    lead OTHER

Principal Investigators

  • Noel BLETTNER, MD · Mercy Hospital CHR Metz Thionville

  • Azzeddine AZZEMOU, MD · Bel Air Hospital CHR Metz Thionville

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-03-07
Primary Completion
2029-09-07
Completion
2029-09-21

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05475574 on ClinicalTrials.gov